Search Results - "Dubreuil, O."

RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study by Bachet, J.B., Bouché, O., Taieb, J., Dubreuil, O., Garcia, M.L., Meurisse, A., Normand, C., Gornet, J.M., Artru, P., Louafi, S., Bonnetain, F., Thirot-Bidault, A., Baumgaertner, I., Coriat, R., Tougeron, D., Lecomte, T., Mary, F., Aparicio, T., Marthey, L., Taly, V., Blons, H., Vernerey, D., Laurent-Puig, P.

“…RAS mutations are currently sought for in tumor samples, which takes a median of almost 3weeks in western European countries. This creates problems in clinical…”
Get full text

Reasons for chemotherapy discontinuation and end of life in gastro-intestinal cancers: a multicentric prospective AGEO study by Palmieri, L., Dubreuil, O., Hautefeuille, V., Bachet, J., Trouilloud, I., Locher, C., Coriat, R., Moryoussef, F., Landi, B., Perkins, G., Doat, S.

Get full text

Roughness evolution of sol–gel optical coatings by ion beam sputtering by Gailly, P., Dubreuil, O., Fleury-Frenette, K.

“…The surface roughness evolution of two silica-based sol-gel materials under 650eV argon ion beam sputtering has been investigated. The liquid sol-gel solutions…”
Get full text

Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study by Gallois, C., Bergen, E.S., Auclin, É., Pernot, S., Higué, J., Trouilloud, I., Touchefeu, Y., Turpin, A., Mazard, T., Sartore-Bianchi, A., Prenen, H., Alberti, A., Pilla, L., Cuissy, S., Wookey, V., Perret, A., Melchior, C., Artru, P., Dubreuil, O., Drouillard, A., Doat, S., Lavolé, J., Basile, D., Perkins, G., Jary, M., Stintzing, S., Ros, J., Tougeron, D., Taieb, J.

“…The combination of encorafenib with cetuximab has become the standard of care in patients with BRAF V600E-mutated metastatic colorectal cancer (mCRC) after a…”
Get full text

2316 Efficacy and toxicity of second-line chemotherapy in patients with advanced oesophageal squamous cell carcinoma progressing after a first line of 5-fluorouracil and platinum-based therapy: An AGEO retrospective multicentric study by Auzolle, C, Dubreuil, O, Pozet, A, Coriat, R, Dhooge, M, Ducreux, M, Mons, M, Brieau, B, Baumgaertner, I, Gornet, J.M, Li évre, A, Locher, C, Mary, F, Bonnetain, F, Landi, B

Get full text

TiO2 mesoporous thin films studied by Atmospheric Ellipsometric Porosimetry: A case of contamination by DUBREUIL, O, DEWALQUE, J, CHENE, G, MATHS, F, SPRONCK, G, STRIVAY, D, CLOOTS, R, HENRIST, C

“…Anatase mesoporous TiO2 thin films are frequently prepared by surfactant templating to control porosity development and Atmospheric Ellipsometric Porosimetry is…”
Get full text

mesoporous thin films studied by Atmospheric Ellipsometric Porosimetry: A case of contamination by Dubreuil, O., Dewalque, J., Chêne, G., Mathis, F., Spronck, G., Strivay, D., Cloots, R., Henrist, C.

Get full text

Characterization of copper grain growth limitations inside narrow wires depending of overburden thickness by Dubreuil, O., Cordeau, M., Mourier, Th, Chausse, P., Mellier, M., Bellet, D., Torres, J.

“…With the downscaling of feature dimensions, copper interconnects exhibit properties differing from bulk or film material. Resistivity increases and limits…”
Get full text

Adventitia measurement in coronary artery: an in vivo intravascular ultrasound study by Rioufol, G, Elbaz, M, Dubreuil, O, Tabib, A, Finet, G

Get full text

Characterization and impact of reduced copper plating overburden on 45 nm interconnect performances by Dubreuil, O., Caubet-Hilloutou, V., Guillan, J., Haxaire, K., Mellier, M., Caubet, P., Vannier, P., Petitprez, E., Bellet, D., Normandon, Ph

“…During first metal level interconnects fabrication, a controlled modification of the electro-deposited copper over-deposition (overburden) is performed using a…”
Get full text

Characterization and impact of reduced copper plating overburden on 45nm interconnect performances by Dubreuil, O., Caubet-Hilloutou, V., Guillan, J., Haxaire, K., Mellier, M., Caubet, P., Vannier, P., Petitprez, E., Bellet, D., Normandon, Ph

Get full text

Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry by Souteyrand, Geraud, Amabile, Nicolas, Mangin, Lionel, Chabin, Xavier, Meneveau, Nicolas, Cayla, Guillaume, Vanzetto, Gerald, Barnay, Pierre, Trouillet, Charlotte, Rioufol, Gilles, Rangé, Gregoire, Teiger, Emmanuel, Delaunay, Regis, Dubreuil, Olivier, Lhermusier, Thibault, Mulliez, Aurélien, Levesque, Sebastien, Belle, Loic, Caussin, Christophe, Motreff, Pascal

“…Angiography has limited value for identifying the causes of stent thrombosis (ST). We studied a large cohort of patients by optical coherence tomography (OCT)…”
Get full text

Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study by Phelip, Jean Marc, Desrame, Jérôme, Edeline, Julien, Barbier, Emilie, Terrebonne, Eric, Michel, Pierre, Perrier, Hervé, Dahan, Laetitia, Bourgeois, Vincent, Akouz, Faiza Khemissa, Soularue, Emilie, Ly, Valérie Lebrun, Molin, Yann, Lecomte, Thierry, Ghiringhelli, François, Coriat, Romain, Louafi, Samy, Neuzillet, Cindy, Manfredi, Sylvain, Malka, David

“…Whether triplet chemotherapy is superior to doublet chemotherapy in advanced biliary tract cancer (BTC) is unknown. In this open-label, randomized phase II-III…”
Get full text

625P Efficacy and safety of the combination of encorafenib and cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: An AGEO real-world multicentre study by Gallois, C., Elez Fernandez, M.E., Auclin, E., Bergen, E.S., Pernot, S., Higué, J., Trouilloud, I., Touchefeu, Y., Turpin, A., Mazard, T., Pilla, L., Cuissy, S., Wookey, V., Perret, A., Melchior, C., Artru, P., Stintzing, S., Dubreuil, O., Tougeron, D., Taieb, J.

Get full text

1555P Cell-free DNA analysis in patients with metastatic gastroesophageal adenocarcinoma: Preliminary results of the REGIRI - PRODIGE 58 ancillary study by Harlé, A., Merigout, A., Evesque, L., Turpin, A., Tougeron, D., Botsen, D., Muller, M., de la Fouchardiere, C., Dubreuil, O., Zaanan, A., Bouche, O., Ben Abdelghani, M., Watson, S., Dermeche, S., Khemissa Akouz, F., Husson, M., Merlin, J.L., Bach, A-S., Senellart, H., Samalin-Scalzi, E.

Get full text

P-362Reasons for chemotherapy discontinuation and end of life in gastro-intestinal cancers: a multicentric prospective AGEO study by Palmieri, L, Dubreuil, O, Hautefeuille, V, Bachet, J, Trouilloud, I, Locher, C, Coriat, R, Moryoussef, F, Landi, B, Perkins, G, Doat, S

Get full text

443P First-line chemotherapy with raltitrexed in metastatic colorectal cancer: An AGEO multicentre study by Gallois, C., Hafliger, E., Auclin, E., Perret, A., Artru, P., Coutzac, C., Turpin, A., Pellat, A., Randrian, V., Basile, D., Faroux, R., Locher, C., Hautefeuille, V., Dubreuil, O., Palmieri, L-J., Dior, M., Taieb, J.

Get full text

Incidence and predictors of in-hospital complications after myocardial infraction in contemporary clinical practice: Findings from the FRENCHIE myocardial infarction cohort by Lemesle, G., Cayla, G., Gallet de Saint Aurin, R., Nekrouf, C., Rousseau, A., Ducrocq, G., Angoulvant, D., Coste, P., Boccara, F., Lhermusier, T., Barone Rochette, G., Dubreuil, O., Steg, P.G., Danchin, N., Simon, T.

Get full text

435P Bevacizumab (bev) continuation with FOLFIRI or switch to aflibercept (afli) with FOLFIRI as second-line treatment (L2) after first line of FOLFOX-bev (L1) for metastatic colorectal cancer (mCRC): An AGEO multicenter study by Torregrosa, C., Pernot, S., Perret, A., Randrian, V., Doat, S. Racine, Auberger, B., Godet, T., Jaffrelot, M., Dubreuil, O., Turpin, A., Palmieri, L-J., Bouche, O., Lecomte, T., Sefrioui, D., Locher, C., Neuzillet, C., Nassif, E., Lecaille, C., Taieb, J., Auclin, E.

Get full text

Regression of Q waves and clinical outcomes following primary PCI in anterior STEMI by de Framond, Yuni, Schaaf, Mathieu, Pichot-Lamoureux, Sophie, Range, Grégoire, Dubreuil, Olivier, Angoulvant, Denis, Claeys, Marc J., Dorado, David Garcia, Bochaton, Thomas, Rioufol, Gilles, Jossan, Claire, Boussaha, Inesse, Ovize, Michel, Mewton, Nathan

“…Pathological Q waves are correlated with infarct size, and Q-wave regression is associated with left ventricular ejection fraction improvement. There are…”
Get full text